Combination of EGRF and transforming growth factor beta shows promising results for treating metastatic head and neck squamous cell carcinoma.Read More
Foundational Research Yields Clues to Understanding Early-Onset Colorectal Cancer
Researchers conduct parallel studies to better understand early-onset colorectal cancer.
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials
The Community Outreach group at Cleveland Clinic’s Taussig Cancer Center sought input from people at local faith-based organizations to better understand and address the history of health disparities in the community.
Mitochondria Transfer From Healthy Astrocytes Fuels Glioblastoma Tumorigenicity
Glioblastoma cells use mitochondria from the central nervous system to grow and form more aggressive tumors, a new study finds. The finding suggests new opportunities for therapeutic development.
Study Supports Updates to Staging Systems for Cutaneous Squamous Cell Carcinoma
Researchers are seeking to update staging guidelines for cutaneous squamous cell carcinoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic Led Study Shows Bariatric Surgery Reduces Risk of Cancer
A multicenter cohort study of patients with obesity suggests a decreased risk of developing new obesity-related cancers in patients with a history of bariatric surgery.
The Role of Nomograms in Treatment Evaluation for Cancer Patients (Podcast)
Nomograms can aid oncologists in predicting treatment effectiveness for patients with breast and prostate cancer.
Advanced Thyroid Cancer: Combined Transcervical and Transthoracic Surgical Approaches
A new study indicates that the combined approaches can be performed without mortality and with acceptable morbidity.
10 ASCO Presentations You Don’t Want to Miss
Cleveland Clinic shares top research abstracts to check out at the 2023 ASCO annual meeting.
Lasofoxifene Combination Therapy Shows Promise for Treatment-Resistant Breast Cancer
A combination of lasofoxifene and abemaciclib improves overall survival in heavily pretreated patients with ER-positive, HER2-negative metastatic breast cancer.
Immunotherapy a Game Changer for Case of Advanced Cutaneous Squamous Cell Carcinoma
A patient with advanced cutaneous squamous cell carcinoma achieved a near complete response from immunotherapy.